Status:
COMPLETED
Circulating Biomarkers and Ventricular Tachyarrhythmia
Lead Sponsor:
Ochsner Health System
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Cardiomyopathy
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether levels of inflammatory markers in circulating blood can correlate with risk for dangerous heart rhythms. Patients with systolic heart failure, which h...
Detailed Description
If you agree to be in this study, you will be asked to the following things: * you will come into the EP device clinic every three months for one year to have your device interrogated and will comple...
Eligibility Criteria
Inclusion
- left ventricular ejection fraction \[LVEF\] \<=35%
- ICD implant
Exclusion
- Recent myocardial infarction (12 weeks)
- Recent revascularization (12 weeks)
- Recent hospitalization for any cause (6 weeks)
- History of rheumatologic disease
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT01892462
Start Date
June 1 2012
End Date
October 1 2016
Last Update
April 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ochsner Health System
New Orleans, Louisiana, United States, 70121